A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen

Erika Cecchin,Mario D'Andrea,Sara Lonardi,Chiara Zanusso,Nicoletta Pella,D. Errante,E. De Mattia,Jerry Polesel,Federico Innocenti,Giuseppe Toffoli

A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen

2013

Erika Cecchin
Mario D'Andrea
Sara Lonardi
Chiara Zanusso
Nicoletta Pella
D. Errante
E. De Mattia
Jerry Polesel
Federico Innocenti
Giuseppe Toffoli

A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen

Keywords:

Pharmacology
Regimen
Prospective cohort study
Pharmacogenomics
Pharmacogenetics
Fluorouracil
Adjuvant
Colorectal cancer
Oxaliplatin
Biology
Odds ratio
Neutropenia

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations